Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression

Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective treatments and ranks as the second most lethal tumor. Immunotherapy has brought great hope for HCC treatment. Oxysophocarpine is a bioactive alkaloid which poses various pharmacological functions including neuroprotect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianchu, Wei, Wang, Tang, Qianli, Lu, Libai, Luo, Zongjiang, Li, Wenchuan, Lu, Yuan, Pu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541159/
https://www.ncbi.nlm.nih.gov/pubmed/32810392
http://dx.doi.org/10.1002/cam4.3151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541159/
https://www.ncbi.nlm.nih.gov/pubmed/32810392
http://dx.doi.org/10.1002/cam4.3151

Ejemplares similares